Executive perspective

Cencora’s Participation in the White House Cancer Moonshot’s New Pilot to Mitigate Pediatric Cancer Drug Shortages

Cencora is proud to serve as a participant in the White House Cancer Moonshot’s initiative, which aims to mitigate shortages of critical pediatric cancer medications. As a leader in pharmaceutical supply chain operations and distribution, Cencora is committed to advance solutions that create stability for our nation’s pharmaceutical products and help to ensure healthcare providers have timely and reliable access to medications. We believe continued collaboration with multiple stakeholders across the industry is critical to strengthen the supply chain and address this complex, multi-faceted issue.

- Heather Zenk, RPh, PharmD, President of the U.S. Supply Chain, Cencora


Media mention

Cencora Leaders Share Insights at Asembia AXS26, Affirming Commitment to Accelerating Access to Innovative Specialty Medicines

May 6, 2026

Media mention

Pharmaceutical supply chain experts discuss the transition to the FDA’s new 12-digit NDC format with Drug Topics and Pharmaceutical Commerce

April 24, 2026

Press release

Cencora Report Reveals Payer Trends Shaping Coverage for Cell and Gene Therapies

March 27, 2026

Media contacts

Need help or have questions?  Send us a message and we'll get back to you soon.